According to Libang Instruments, Libang recently signed a licensing and commercialization agreement with Global Health Labs, Inc. (“GH Labs”). The two sides will integrate professional advantages and advanced global technical resources to jointly develop an economical handheld ultrasound device based on artificial intelligence technology to provide technical support for actions to reduce global maternal and child mortality, and work together to improve the health standards of women and children in low- and middle-income countries.
理邦仪器与GH Labs签署许可和商业化协议 破局“AI+掌上超声”
Libang Instruments and GH Labs sign licensing and commercialization agreement to break the “AI+ Pocket Ultrasound” game
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.